OpenRegistry
Companies House/London/Company profile

KESMALEA THERAPEUTICS LIMITED

Active
12961631·incorporated 2020-10-20

KESMALEA THERAPEUTICS LIMITED is an active UK private limited company, incorporated on 20 October 2020 at Companies House (number 12961631; OpenRegistry canonical ID GB-12961631-kesmalea-therapeutics-limited). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,267 active UK entities in that code and one of 1,107,954 active companies registered in London (postcode WC1B). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2020-10-20
Registered Address
2ND FLOOR, 8, BLOOMSBURY STREET, LONDON, WC1B 3SR, ENGLAND
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Last filed accounts made up to 2025-03-31. Next accounts due 2026-12-31. Financial year-end: 31/03. Filing class: SMALL.

Confirmation statement

Last confirmation statement made up to 2025-10-19. Next confirmation statement due 2026-11-02.

Mortgages and charges

2 charges recorded against the company at Companies House: 1 outstanding, 1 satisfied, 0 partially satisfied.

Persons with significant control

KESMALEA THERAPEUTICS LIMITED has 1 person with significant control on file:

  • Syncona Limited (Guernsey reg. 55514). Notified 2022-09-08.
    • Owns 50–75% of shares
    • Holds 50–75% of voting rights

1 historical PSC record has ceased:

  • Harry Finch born 1948 resident in England, British national. Notified 2020-10-20. Ceased 2022-09-08.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
    • Has the right to appoint and remove directors

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in London: